Neumirna Therapeutics is thrilled to announce the successful closing of a $20 million funding round, a significant milestone that will propel our mission of developing cutting-edge RNA therapeutics for the treatment of neurological disorders. This latest investment will enhance our research and development efforts, paving the way for innovative therapies aimed at modifying the underlying mechanisms of diseases such as Alzheimer's, Parkinson's, and multiple sclerosis. Recognizing the pressing need for effective treatments in the arena of neurology, Neumirna Therapeutics is committed to harnessing the potential of RNA technology to deliver targeted and precise interventions. With this infusion of capital, we plan to expand our preclinical studies and advance our pipeline of therapeutic candidates, ensuring that we remain at the forefront of neurological research. Additionally, the funding will support our talented team of scientists and researchers, enabling them to explore the full breadth of possibilities that RNA therapeutics hold. As we embark on this exciting new chapter, we express our gratitude to our investors for their confidence in our vision and our commitment to transforming the landscape of neurological disease treatment. We firmly believe that through collaboration and innovation, Neumirna Therapeutics can achieve significant breakthroughs that hold promise for millions suffering from these challenging conditions. Keep an eye on us as we progress toward our goal of making a meaningful difference in the lives of patients and their families.
Neumirna Therapeutics Secures $20 Million in Series A Funding Round for RNA Therapeutics Development in Neurological Disorders
Recently funded · €20.0M Series aPharmaceutical
Get the full Neumirna Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)
